2630 Avelumab (MSB0010718C), an anti-PD-L1 antibody, in patients with locally advanced or metastatic urothelial carcinoma: A phase Ib trial
Apolo, A.B., Infante, J.R., Hamid, O., Patel, M., Wang, D., Kelly, K., Mega, A., Britten, C.D., Mita, A., Ravaud, A., Cuillerot, J.M., Von Heydebreck, A., Gulley, J.L.Volume:
51
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/s0959-8049(16)31447-2
Date:
September, 2015
File:
PDF, 60 KB
english, 2015